UK SMI B 11: investigation of swabs from skin and superficial soft tissue infections
This consultation has concluded
Download the full outcome
Detail of outcome
Detail of feedback received
Timeline of review process
Date review started: 1 July 2013
First consultation: 6 January 2015 to 26 January 2015
Second consultation: 7 September 2015 to 5 October 2015
Document discussed at the following working group meetings:
- 27 November 2013
- 25 June 2014
- 12 February 2015
- 24 June 2015
- 21 October 2015
Date document issued: 4 May 2016
This consultation ran from
This consultation asks for feedback in relation to the UK SMI B 11: investigation of swabs from skin and superficial soft tissue infections.
Ref: PHE publications gateway number: 2015306 PDF, 1.23MB, 33 pages
Ref: PHE publications gateway number: 2015306 MS Word Document, 1.57MB
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
Under consultation - updated documents now live
These documents have been reissued to include amended antibiotic susceptibility and reporting tables. Available for comment as of 24 September 2015.
Public Health England has opened a consultation this week in joint partnership with professional organisations.
This consultation asks for feedback in relation to the Standards for Microbiology Investigations B 11: investigation of swabs from skin and superficial soft tissue infections. In order to support antimicrobial stewardship programmes, this SMI includes new guidance on the selective testing and reporting of antimicrobials. The guidelines have been developed in conjunction with the British Society for Antimicrobial Chemotherapy and have the support of ARHAI, PHE Colindale. They are intended to support and complement local antimicrobial guidance and as such are not intended to be over-prescriptive.
To comment on the document, the concept of antimicrobial susceptibility testing and reporting tables and the content of the antimicrobial susceptibility tables please use the consultation form below.
We have refined the process so that UK SMI users can comment more easily if they see no requirement for amendments to the document out for consultation.
This information is as important to the consultation process as comments.